Annual Gross Profit
$73.35 M
+$16.65 M+29.36%
31 December 2023
Summary:
UroGen Pharma annual gross profit is currently $73.35 million, with the most recent change of +$16.65 million (+29.36%) on 31 December 2023. During the last 3 years, it has risen by +$62.56 million (+579.81%). URGN annual gross profit is now at all-time high.URGN Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$22.75 M
+$3.13 M+15.96%
30 September 2024
Summary:
UroGen Pharma quarterly gross profit is currently $22.75 million, with the most recent change of +$3.13 million (+15.96%) on 30 September 2024. Over the past year, it has increased by +$4.27 million (+23.08%). URGN quarterly gross profit is now at all-time high.URGN Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$80.67 M
+$4.27 M+5.58%
30 September 2024
Summary:
UroGen Pharma TTM gross profit is currently $80.67 million, with the most recent change of +$4.27 million (+5.58%) on 30 September 2024. Over the past year, it has increased by +$12.73 million (+18.74%). URGN TTM gross profit is now at all-time high.URGN TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.4% | +23.1% | +18.7% |
| 3 y3 years | +579.8% | +125.1% | +126.5% |
| 5 y5 years | +10000.0% | +100.0% | +10000.0% |
URGN Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +579.8% | at high | +125.1% | at high | +126.5% |
| 5 y | 5 years | at high | >+9999.0% | at high | at high | >+9999.0% | |
| alltime | all time | at high | >+9999.0% | at high | +3047.0% | at high | >+9999.0% |
UroGen Pharma Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.75 M(+16.0%) | $80.67 M(+5.6%) |
| June 2024 | - | $19.62 M(+15.0%) | $76.40 M(+1.2%) |
| Mar 2024 | - | $17.05 M(-19.7%) | $75.48 M(+2.9%) |
| Dec 2023 | $73.35 M(+29.4%) | $21.24 M(+14.9%) | $73.35 M(+8.0%) |
| Sept 2023 | - | $18.48 M(-1.1%) | $67.94 M(+6.9%) |
| June 2023 | - | $18.70 M(+25.2%) | $63.53 M(+6.6%) |
| Mar 2023 | - | $14.93 M(-5.7%) | $59.59 M(+5.1%) |
| Dec 2022 | $56.70 M(+32.2%) | $15.83 M(+12.4%) | $56.70 M(+2.2%) |
| Sept 2022 | - | $14.08 M(-4.6%) | $55.46 M(+7.7%) |
| June 2022 | - | $14.76 M(+22.6%) | $51.49 M(+6.5%) |
| Mar 2022 | - | $12.04 M(-17.5%) | $48.34 M(+12.7%) |
| Dec 2021 | $42.88 M(+297.5%) | $14.59 M(+44.3%) | $42.88 M(+20.4%) |
| Sept 2021 | - | $10.11 M(-12.9%) | $35.61 M(+24.3%) |
| June 2021 | - | $11.61 M(+76.2%) | $28.66 M(+64.9%) |
| Mar 2021 | - | $6.59 M(-9.9%) | $17.38 M(+61.1%) |
| Dec 2020 | $10.79 M | $7.31 M(+132.0%) | $10.79 M(+210.4%) |
| Sept 2020 | - | $3.15 M(+872.8%) | $3.48 M(+972.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $324.00 K(>+9900.0%) | $324.00 K(+1700.0%) |
| Mar 2020 | - | $0.00(0.0%) | $18.00 K(0.0%) |
| Dec 2019 | $18.00 K(-102.7%) | $0.00(0.0%) | $18.00 K(0.0%) |
| Sept 2019 | - | $0.00(-100.0%) | $18.00 K(-102.4%) |
| June 2019 | - | $18.00 K(>+9900.0%) | -$754.00 K(+3.9%) |
| Mar 2019 | - | $0.00(0.0%) | -$726.00 K(+7.6%) |
| Dec 2018 | -$675.00 K(-108.9%) | $0.00(-100.0%) | -$675.00 K(+6.3%) |
| Sept 2018 | - | -$772.00 K(-1778.3%) | -$635.00 K(-108.3%) |
| June 2018 | - | $46.00 K(-9.8%) | $7.65 M(+0.6%) |
| Mar 2018 | - | $51.00 K(+27.5%) | $7.61 M(+0.7%) |
| Dec 2017 | $7.56 M(-56.8%) | $40.00 K(-99.5%) | $7.56 M(-69.8%) |
| Sept 2017 | - | $7.52 M(>+9900.0%) | $25.02 M(+42.9%) |
| Mar 2017 | - | $1000.00(-100.0%) | $17.50 M(+0.0%) |
| Dec 2016 | $17.50 M(>+9900.0%) | $17.50 M(>+9900.0%) | $17.50 M(>+9900.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2016 | - | $0.00 | $0.00 |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is UroGen Pharma annual gross profit?
- What is the all time high annual gross profit for UroGen Pharma?
- What is UroGen Pharma annual gross profit year-on-year change?
- What is UroGen Pharma quarterly gross profit?
- What is the all time high quarterly gross profit for UroGen Pharma?
- What is UroGen Pharma quarterly gross profit year-on-year change?
- What is UroGen Pharma TTM gross profit?
- What is the all time high TTM gross profit for UroGen Pharma?
- What is UroGen Pharma TTM gross profit year-on-year change?
What is UroGen Pharma annual gross profit?
The current annual gross profit of URGN is $73.35 M
What is the all time high annual gross profit for UroGen Pharma?
UroGen Pharma all-time high annual gross profit is $73.35 M
What is UroGen Pharma annual gross profit year-on-year change?
Over the past year, URGN annual gross profit has changed by +$16.65 M (+29.36%)
What is UroGen Pharma quarterly gross profit?
The current quarterly gross profit of URGN is $22.75 M
What is the all time high quarterly gross profit for UroGen Pharma?
UroGen Pharma all-time high quarterly gross profit is $22.75 M
What is UroGen Pharma quarterly gross profit year-on-year change?
Over the past year, URGN quarterly gross profit has changed by +$4.27 M (+23.08%)
What is UroGen Pharma TTM gross profit?
The current TTM gross profit of URGN is $80.67 M
What is the all time high TTM gross profit for UroGen Pharma?
UroGen Pharma all-time high TTM gross profit is $80.67 M
What is UroGen Pharma TTM gross profit year-on-year change?
Over the past year, URGN TTM gross profit has changed by +$12.73 M (+18.74%)